1 Stock to Buy, 1 Stock to Sell This Week: Apple, AMD
Fed rate hike, Powell comments, U.S. jobs report, and more earnings will drive sentiment this week. Apple stock is a buy with earnings due on Thursday. AMD shares are a sell amid...
Fed rate hike, Powell comments, U.S. jobs report, and more earnings will drive sentiment this week. Apple stock is a buy with earnings due on Thursday. AMD shares are a sell amid...
May is expected to be another volatile month on Wall Street. Investor focus will be on the Federal Reserve’s policy meeting, the monthly jobs report, inflation data, more...
Moderna (NASDAQ:MRNA) shares closed lower on Tuesday after the vaccine maker said that its vaccine against seasonal flu did not achieve “early success” in the Phase 3...
In 2022, the vast majority of hedge funds struggled to generate returns for their investors. As stock-picking funds generated negative returns, global macro funds came out the big...
Biotech company Moderna (NASDAQ:MRNA) is seeing its shares trade under pressure in recent days after the company reported last week Phase 3 trial results for its flu vaccine...
PCE inflation data, Fed FOMC minutes, retailer earnings in focus. Walmart stock is a buy amid strong results, upbeat guidance. Moderna shares set to underperform on big profit...
Fed rate hike, U.S. jobs report, more earnings in focus Devon Energy stock is a buy with strong Q3 earnings ahead Robinhood set to struggle amid shrinking revenue, fewer...
If there was an over-arching theme that encapsulated the events related to the markets this week, it was there was no middle of the road. Examples of extremes – as in, the biggest,...
MRNA is an exceptionally difficult stock to value, given enormous uncertainty surrounding its COVID-19 vaccine and other drugs in its pipeline But there is a case that an...
The steep plunge in Moderna stock comes amid signs that the pandemic is moving towards an endemic stage The company still maintains a strong sales pipeline for its COVID vaccines,...